Related Experiment Video
Updated: Apr 19, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes
Toni Urbanik1, Bruno Christian Koehler1, Laura Wolpert1
1Toni Urbanik, Bruno Christian Koehler, Laura Wolpert, Christin Elßner, Anna-Lena Scherr, Nicole Kautz, Stefan Welte, Dirk Jäger, Henning Schulze-Bergkamen, National Center for Tumor Diseases, Department of Medical Oncology, University Clinic of Heidelberg, 69120 Heidelberg, Baden-Wuerrtemberg, Germany.
Aim:
To analyze the role of CYLD for receptor-mediated cell death of murine hepatocytes in acute liver injury models.
Methods:
Hepatocyte cell death in CYLD knockout mice (CYLD(-/-) ) was analyzed by application of liver injury models for CD95- (Jo2) and tumor necrosis factor (TNF)-α- [D-GalN/lipopolysaccharide (LPS)] induced apoptosis. Liver injury was assessed by measurement of serum transaminases and histological analysis. Apoptosis induction was quantified by cleaved PARP staining and Western blotting of activated caspases. Nuclear factor (NF)-κB, ERK, Akt and jun amino-terminal kinases signaling were assessed. Primary Hepatocytes were isolated by two step-collagenase perfusion and treated with recombinant TNF-α and with the CD95-ligand Jo2. Cell viability was analyzed by MTT-assay.
Results:
Livers of CYLD(-/-) mice showed increased anti-apoptotic NF-κB signaling. In both applied liver injury models CYLD(-/-) mice showed a significantly reduced apoptosis sensitivity. After D-GalN/LPS treatment CYLD(-/-) mice exhibited significantly lower levels of alanine aminotransferase (ALT) (295 U/L vs 859 U/L, P < 0.05) and aspartate aminotransferase (AST) (560 U/L vs 1025 U/L, P < 0.01). After Jo injection CYLD(-/-) mice showed 2-fold lower ALT (50 U/L vs 110 U/L, P < 0.01) and lower AST (250 U/L vs 435 U/L, P < 0.01) serum-levels compared to WT mice. In addition, isolated CYLD(-/-) primary murine hepatocytes (PMH) were less sensitive towards death receptor-mediated apoptosis and showed increased levels of Bcl-2, XIAP, cIAP1/2, survivin and c-FLIP expression upon TNF- and CD95-receptor triggering, respectively. Inhibition of NF-κB activation by the inhibitor of NF-κB phosphorylation inhibitor BAY 11-7085 inhibited the expression of anti-apoptotic proteins and re-sensitized CYLD(-/-) PMH towards TNF- and CD95-receptor mediated cell death.
Conclusion:
CYLD is a central regulator of apoptotic cell death in murine hepatocytes by controlling NF-κB dependent anti-apoptotic signaling.
Insights
CYLD deficiency protects against liver injury by reducing hepatocyte apoptosis. This occurs through enhanced NF-κB signaling, which increases anti-apoptotic protein expression, making hepatocytes less sensitive to death receptor-mediated cell death.
Area of Science:
- Hepatology and Immunology
- Molecular Biology
- Cell Death Research
Background:
- Receptor-mediated apoptosis plays a critical role in liver injury.
- The CYLD (CYLD Lysine 63 Deubiquitinase) gene's function in hepatocyte apoptosis is not fully understood.
- Understanding CYLD's role is crucial for developing therapeutic strategies against acute liver injury.
Purpose of the Study:
- To investigate the role of CYLD in receptor-mediated apoptosis of murine hepatocytes.
- To analyze the impact of CYLD deficiency on acute liver injury models.
Main Methods:
- Utilized CYLD knockout (CYLD(-/-)) and wild-type (WT) mice in CD95- (Jo2) and tumor necrosis factor-α (TNF-α) [D-GalN/lipopolysaccharide (LPS)] induced liver injury models.
- Assessed liver injury via serum transaminases (ALT, AST) and histological analysis.
- Quantified apoptosis using cleaved PARP staining, Western blotting for activated caspases, and MTT assays on primary hepatocytes.
Main Results:
- CYLD(-/-) mice exhibited significantly reduced apoptosis sensitivity in both liver injury models, with lower ALT and AST levels compared to WT mice.
- CYLD deficiency led to increased anti-apoptotic nuclear factor-kappa B (NF-κB) signaling in hepatocytes.
- Isolated CYLD(-/-) primary murine hepatocytes (PMH) showed increased expression of anti-apoptotic proteins (Bcl-2, XIAP, cIAP1/2, survivin, c-FLIP) and were less sensitive to TNF-α and CD95-ligand induced cell death.
Conclusions:
- CYLD acts as a key regulator of apoptotic cell death in murine hepatocytes.
- CYLD controls NF-κB-dependent anti-apoptotic signaling pathways.
- CYLD deficiency confers protection against acute liver injury by modulating hepatocyte apoptosis.
Related Concept Videos
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Cellular Injury V: Apoptosis and Autophagy
Cirrhosis II: Pathophysiology

